SEC 13F Intelligence

Privium Fund Management B.V. / APLSUSD

Privium Fund Management B.V.’s Apellis Pharmaceuticals Inc Position

Does Privium Fund Management B.V. own Apellis Pharmaceuticals Inc (APLSUSD)? Not currently — the last reported position was 92.6K shares worth $6M in Q3 2022; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$6M
Q3 2022
Shares
92.6K
% of Portfolio
+2.20%
Quarters Held
4
position exited

Position History APLSUSD

Reported value by quarter
Q4 ’21: $6MQ4 ’21Q1 ’22: $7MQ1 ’22Q2 ’22: $6MQ2 ’22Q3 ’22: $6MQ3 ’22filingsflow.com
QuarterSharesValue% of Portfolio
Q3 202292.6K$6M+2.20%
Q2 2022137.6K$6M+2.06%
Q1 2022137.6K$7M+1.55%
Q4 2021127.6K$6M+1.21%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Privium Fund Management B.V.’s full portfolio or all institutional holders of APLSUSD.